Literature DB >> 2685600

Impotence.

R J Krane1, I Goldstein, I Saenz de Tejada.   

Abstract

Mesh:

Year:  1989        PMID: 2685600     DOI: 10.1056/NEJM198912143212406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

1.  Health-related quality of life in a UK-based population of men with erectile dysfunction.

Authors:  Julian F Guest; Roben Das Gupta
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 4.  [Therapy for organic erectile dysfunction].

Authors:  A J Becker; M Mayer; C G Stief
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 5.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

6.  Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat.

Authors:  J P Finberg; Y Vardi
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  The ED-EQoL: the development of a new quality of life measure for patients with erectile dysfunction.

Authors:  R P MacDonagh; T Porter; D Pontin; P Ewings
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 8.  Intracavernous prostaglandin E1 in erectile dysfunction.

Authors:  O I Linet; L L Neff
Journal:  Clin Investig       Date:  1994-01

9.  Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate.

Authors:  A Gomaa; M Shalaby; M Osman; M Eissa; A Eizat; M Mahmoud; N Mikhail
Journal:  BMJ       Date:  1996-06-15

Review 10.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.